NASDAQ · Financial Statements

Telomir Pharmaceuticals, Inc. (TELO) Financial Statements

$1.12 NASDAQ: TELO Market Cap $77.03M

Telomir Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-10.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$-1.0M$-4.0M$-12.0M$-11.0M
Net Profit$0$-1.0M$-13.0M$-17.0M$-10.0M
EPS$0.00$-0.03$-0.44$-0.56$-0.33
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$5.0M$1.0M$7.0M
Total Liabilities$0$1.0M$1.0M$1.0M$1.0M
Cash$0$0$0$1.0M$7.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-4.0M$-5.0M$-4.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$1.0M$6.0M
Free Cash Flow$0$0$-4.0M$-5.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-12.94
FCF Yield-6.06%
Quick Ratio16.14
Interest Coverage-867.98
Return 1Y8.09%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
TELO Overview TELO Dividend Run Stock Screener